Reprofiling of approved drugs against SARS-CoV-2 main protease: an in-silico study-Reference-Cited by-同舟云学术

Reprofiling of approved drugs against SARS-CoV-2 main protease: an in-silico study

Published:2020-11-12 Issue: Volume: Page:1-15
ISSN:0739-1102
Container-title:Journal of Biomolecular Structure and Dynamics
language:en
Short-container-title:Journal of Biomolecular Structure and Dynamics

Author:

Kumar Prateek¹^ORCID,Bhardwaj Taniya¹^ORCID,Kumar Ankur¹,Gehi Bhuvaneshwari R.¹,Kapuganti Shivani K.¹,Garg Neha²^ORCID,Nath Gopal³,Giri Rajanish¹^ORCID

Affiliation:

1. School of Basic Sciences, Indian Institute of Technology Mandi, Mandi, Himachal Pradesh, India

2. Department of Medicinal Chemistry, Faculty of Ayurveda, Institute of Medical Sciences, Banaras Hindu University, Varanasi, India

3. Department of Microbiology, Faculty of Medicine, Institute of Medical Sciences, Banaras Hindu University, Varanasi, India

Funder

Department of Biotechnology, Ministry of Science and Technology

Publisher

Informa UK Limited

Subject

Molecular Biology,General Medicine,Structural Biology

Link

https://www.tandfonline.com/doi/pdf/10.1080/07391102.2020.1845976

Reference57 articles.

1. E7 oncoprotein of human papillomavirus: Structural dynamics and inhibitor screening study

2. Coronavirus Main Proteinase (3CL pro ) Structure: Basis for Design of Anti-SARS Drugs

3. Drug repositioning: identifying and developing new uses for existing drugs

4. Octreotide

5. GROMACS: A message-passing parallel molecular dynamics implementation

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. In-silico approach to characterize the structure and function of a hypothetical protein of Monkeypox virus exploring Chordopox-A20R domain-containing protein activity;Antiviral Therapy;2024-05-27

2. Porcine deltacoronavirus nsp5 antagonizes type I interferon signaling by cleaving IFIT3;Journal of Virology;2024-02-20

3. Structure-based virtual screening and Molecular Dynamic Simulations identified FDA-approved molecules as potential inhibitors against the surface proteins of H1N1;2023-12-04

4. Developing a SARS-CoV-2 main protease binding prediction random forest model for drug repurposing for COVID-19 treatment;Experimental Biology and Medicine;2023-11-24

5. Insights into the Interaction Mechanism of Boceprevir with SARS‐CoV‐2 Main Protease;ChemistrySelect;2023-07-26